Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

FEVERTREE DRINKS PLC (FEVR)     

dreamcatcher - 08 Nov 2014 16:51



Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

Chart.aspx?Provider=EODIntra&Code=FEVR&SChart.aspx?Provider=EODIntra&Code=FEVR&SFlag Counter

dreamcatcher - 21 Feb 2017 19:46 - 285 of 711

Cheers Stan, very late for buyers to be buying now.

cynic - 21 Feb 2017 20:04 - 286 of 711

MrC is a very happy bunny :-)

dreamcatcher - 21 Feb 2017 20:09 - 287 of 711

midknight - 22 Feb 2017 10:34 - 288 of 711

22 Feb:

RBC Capital: Outperform - TP: 1700p

Berenberg: Buy - TP:1450p

kimoldfield - 22 Feb 2017 11:40 - 289 of 711

Huh! Didn't want any shares anyway. (Sulk).

dreamcatcher - 22 Feb 2017 15:41 - 290 of 711

skinny - 22 Feb 2017 15:47 - 291 of 711

I hate this share!

dreamcatcher - 22 Feb 2017 15:50 - 292 of 711

I love Marmite as well. :-)) Hope you had a good break skinny.

skinny - 22 Feb 2017 15:55 - 293 of 711

DC - yes thanks.

cynic - 07 Mar 2017 09:43 - 294 of 711

Does one dare mention that sp now stands at 1483 = +27 this morning alone?

kimoldfield - 07 Mar 2017 12:41 - 295 of 711

Don't. Just don't! :o)

cynic - 07 Mar 2017 13:53 - 296 of 711

i confess i'ld find it impossible to persuade myself to buy at these elevated prices
however, completely leaving aside the profits i have taken along the way, my remaining holding was bought at about 595

dreamcatcher - 07 Mar 2017 16:23 - 297 of 711

skinny - 08 Mar 2017 08:56 - 298 of 711

nail.gif

dreamcatcher - 08 Mar 2017 15:54 - 299 of 711

Lol.

dreamcatcher - 09 Mar 2017 17:34 - 300 of 711

dreamcatcher - 09 Mar 2017 19:28 - 301 of 711

Final Result
21 Mar 17 Fevertree Drinks Plc [FEVR]

cynic - 10 Mar 2017 10:57 - 302 of 711

i have something of a luxury problem here
my remaining sipp holding is +181% on cost with figures due imminently

on balance, i think i'll stay put, and if there is a chunky "sell on the news", then i may well add once again

dreamcatcher - 10 Mar 2017 18:52 - 303 of 711

Shares -

The 8 largest companies on AIM
1
ASOS
£4.6bn
2
Abcam
£1.8bn
3
Boohoo.com
£1.7bn
4
Fevertree Drinks
£1.7bn
5
Burford Capital
£1.5bn
6
Hutchison China Meditech
£1.4bn
7
Breedon
£1.1bn
8
James Halstead
£1.0bn

dreamcatcher - 20 Mar 2017 18:03 - 304 of 711

Proactive investor - Make mine a double as Fevertree reports
Share
17:27 20 Mar 2017
More good news is expected from star mixer group Fevertree

Sales have grown a huge 73%
Tonic maker Fevertree Drinks PLC (LON:FEVR) announces its preliminary results Tuesday.
Markets already have a rough guide on what to expect, with the London-based firm revealing back in January that it expects full year revenue to come in at around £102mln, 73% higher than what it reported a year earlier.
The company didn’t guide on profits, but Whitman Howard analyst Chris Wickham expects them to come in ahead of expectations, while Shore Capital analyst Phil Carroll is forecasting a pre-tax profit of £36mln.
The consensus is for diluted earnings per share (EPS) to continue its positive momentum and come in at around 24p, although Wickham is predicting 25.2p.
Given Fevertree’s premium valuation, investors will be keeping a close eye on sales so far in 2017, with continued growth vital to underpin the share price.
Upgrades tend to follow Fevertree announcements, and should overall sales growth show no real sign of slowing, this one could follow a similar theme.
The one slight negative in January’s update was that there seemed to be a half-on-half slowdown in growth in continental Europe and in the USA; two big, as yet unrealised opportunities for the company.
Keep an eye on how things have fared in these markets so far in 2017.
There should also be an update on the company’s new mixers. To try and tap the huge American market (where they prefer dark spirits to, say, gin), Fevertree has been working on new ginger beer products so it’ll be interesting to hear how these are coming along.
Register now or login to post to this thread.